Background: The latest update of the BIG 1-98 study (74 months) applied IPCW to estimate treatment effect in the presence of selective crossover (25% of TAM pts). The IPCW hazard ratio for overall ...
This is a preview. Log in through your library . Abstract This paper deals with two schemes, π-inverse weights and best linear unbiased weights, for weighting of observations drawn by unequal ...
Phase Ib Study for the Combination of Doxorubicin, Dacarbazine, and Nivolumab as the Upfront Treatment in Patients With Advanced Leiomyosarcoma: A Study by the Spanish Sarcoma Group (GEIS) The study ...